Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats.: Comparative study with verapamil

被引:50
作者
Galisteo, M
García-Saura, MF
Jiménez, R
Villar, IC
Wangensteen, R
Zarzuelo, A
Vargas, I
Duarte, J [1 ]
机构
[1] Univ Granada, Fac Farm, Dept Farmacol, E-18071 Granada, Spain
[2] Univ Granada, Sch Med, Dept Physiol, Granada, Spain
关键词
quercetin; verapamil; mineralocorticoid hypertension; antioxidant; vascular reactivity; endothelial dysfunction;
D O I
10.1055/s-2004-818945
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
This study analysed and compared the effects of chronic oral treatment with quercetin or verapamil on systolic blood pressure and vascular function in deoxycorticosterone acetate (DOCA)salt hypertensive rats. Quercetin and verapamil inhibited the development of DOCA-salt-induced hypertension in a similar manner. DOCA-salt-hypertensive rats showed potassium depletion and oxidative stress, prevented only by concomitant quercetin administration. Quercetin and verapamil treatments reduced the endothelium-independent hyper-reactivity to KCI observed in the aorta of DOCA-salt-hypertensive rats, but only quercetin increased the contractile responses to angiotensin 11, improved endothelial dysfunction and restored basal aortic Cu/Zn SOD expression, altered in DOCA-salt-treated rats. In conclusion, quercetin and verapamil show similar antihypertensive effects in mineralocorticoid hypertension, but quercetin was superior to verapamil in improving endothelial-dependent aortic dilatation, suggesting a better vascular protection in this volume expansion hypertension model.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 21 条
  • [1] Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure
    Alvarez, G
    Osuna, A
    Wangensteen, R
    Vargas, F
    [J]. HYPERTENSION, 2000, 35 (03) : 752 - 757
  • [2] Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response
    Beswick, RA
    Zhang, HF
    Marable, D
    Catravas, JD
    Hill, WD
    Webb, RC
    [J]. HYPERTENSION, 2001, 37 (02) : 781 - 786
  • [3] COUNTURE R, 1980, CLIN EXP HYPERTENS, V2, P25
  • [4] VASODILATOR EFFECTS OF QUERCETIN IN ISOLATED RAT VASCULAR SMOOTH-MUSCLE
    DUARTE, J
    PEREZVIZCAINO, F
    ZARZUELO, A
    JIMENEZ, J
    TAMARGO, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) : 1 - 7
  • [5] Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats
    Duarte, J
    Jiménez, R
    O'Valle, F
    Galisteo, M
    Pérez-Palencia, R
    Vargas, F
    Pérez-Vizcaíno, F
    Zarzuelo, A
    Tamargo, J
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1843 - 1854
  • [6] Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats
    Duarte, J
    Galisteo, M
    Ocete, MA
    Pérez-Vizcaino, F
    Zarzuelo, A
    Tamargo, J
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2001, 221 (1-2) : 155 - 160
  • [7] Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats
    Duarte, J
    Pérez-Palencia, R
    Vargas, F
    Ocete, MA
    Pérez-Vizcaino, F
    Zarzuelo, A
    Tamargo, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (01) : 117 - 124
  • [8] FROCHLICH E, 1993, NEW ENGL J MED, V327, P998
  • [9] ON THE MECHANISM OF ANTITHROMBOTIC ACTION OF FLAVONOIDS
    GRYGLEWSKI, RJ
    KORBUT, R
    ROBAK, J
    SWIES, J
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (03) : 317 - 322
  • [10] DIETARY ANTIOXIDANT FLAVONOIDS AND RISK OF CORONARY HEART-DISEASE - THE ZUTPHEN ELDERLY STUDY
    HERTOG, MGL
    FESKENS, EJM
    HOLLMAN, PCH
    KATAN, MB
    KROMHOUT, D
    [J]. LANCET, 1993, 342 (8878) : 1007 - 1011